Device Trial Radar · NCT07390643
The DISCOVER Study
Last checked: Nov 19, 2026Latest source record: Nov 19, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
100
Planned (sponsor's estimate)
Start
Feb 11, 2026
Primary completion
Sep 24, 2026
Study completion Oct 31, 2028
Sponsor
- Lead sponsor
- Dana-Farber Cancer InstituteAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- Feb 5, 2026
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Screening
- FDA-regulated device
- No
- Who can join
- All sexes, from 22 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
The purpose of this research study is to evaluate the possible benefits of screening with an investigational, but commercially available blood test designed to detect many types of cancer. The name of the screening blood test being studied is: -GRAIL Galleri MCED test
Conditions
- Cancer
- Cancer Diagnosis
Interventions
GRAIL Galleri MCED testDevice
A multi-cancer early detection (MCED) blood test.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Multi-cancer Early Detection (MCED) Positive Cancer TypeTime frame: MCED testing will be performed at enrollment, with diagnostic resolution and cancer type determination expected within 12 months.
- Multi-cancer Early Detection (MCED) Positive Cancer IncidenceTime frame: MCED testing will be performed at enrollment, with diagnostic resolution and cancer type determination expected within 12 months.
- Multi-cancer Early Detection (MCED) Positive Cancer StageTime frame: MCED testing will be performed at enrollment, with diagnostic resolution and cancer type determination expected within 12 months.
3 more outcomes with a free account
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Dana-Farber Cancer Institute
Boston, Massachusetts
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.